CYP 269 (Guaifenesin and Phenylephrine 600 mg / 20 mg)

Pill imprint CYP 269 has been identified as Guaifenesin and phenylephrine hydrochloride 600 mg / 20 mg.

Guaifenesin/phenylephrine is used in the treatment of sinus symptoms; cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 600 mg / 20 mg is not a controlled substance under the Controlled Substance Act (CSA).

Guaifenesin and phenylephrine hydrochloride

Imprint:

CYP 269

Strength:

600 mg / 20 mg

Color:

White

Shape:

Elliptical / Oval

Availability:

Rx and/or OTC

Drug Class:

Upper respiratory combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Cypress Pharmaceutical Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.